Published on
October 12, 2021
- 17:30 GMT
Griffon Pharmaceuticals secures exclusive patent license with U.S. Department of Veterans Affairs
Grants worldwide rights to develop and commercialize patent-pending secretin receptor modulators for treating metabolic liver diseases. MONTREAL, QUEBEC, CANADA, October 12, 2021 /EINPresswire.com/ -- Quebec-based Griffon Pharmaceuticals has negotiated …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...